- Home
- HALO vs LEVI Comparison
HALO vs LEVI Comparison
Compare HALO & LEVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- LEVI
- Stock Information
- Founded
- HALO 1998
- LEVI 1853
- Country
- HALO United States
- LEVI United States
- Employees
- HALO N/A
- LEVI N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- LEVI Apparel
- Sector
- HALO Health Care
- LEVI Consumer Discretionary
- Exchange
- HALO Nasdaq
- LEVI Nasdaq
- Market Cap
- HALO 9.0B
- LEVI 9.1B
- IPO Year
- HALO N/A
- LEVI 2019
- Fundamental
- Price
- HALO $65.56
- LEVI $24.38
- Analyst Decision
- HALO Buy
- LEVI Strong Buy
- Analyst Count
- HALO 10
- LEVI 12
- Target Price
- HALO $73.40
- LEVI $24.58
- AVG Volume (30 Days)
- HALO 2.2M
- LEVI 2.5M
- Earning Date
- HALO 10-30-2025
- LEVI 10-09-2025
- Dividend Yield
- HALO N/A
- LEVI 2.12%
- EPS Growth
- HALO 68.93
- LEVI 179.78
- EPS
- HALO 4.37
- LEVI 1.01
- Revenue
- HALO $1,178,672,000.00
- LEVI $6,489,100,000.00
- Revenue This Year
- HALO $32.57
- LEVI N/A
- Revenue Next Year
- HALO $23.25
- LEVI $4.84
- P/E Ratio
- HALO $15.12
- LEVI $24.34
- Revenue Growth
- HALO 34.97
- LEVI 8.29
- 52 Week Low
- HALO $42.01
- LEVI $12.17
- 52 Week High
- HALO $79.50
- LEVI $24.82
- Technical
- Relative Strength Index (RSI)
- HALO 31.20
- LEVI 71.74
- Support Level
- HALO $73.06
- LEVI $22.70
- Resistance Level
- HALO $76.30
- LEVI $24.82
- Average True Range (ATR)
- HALO 2.33
- LEVI 0.55
- MACD
- HALO -1.57
- LEVI 0.09
- Stochastic Oscillator
- HALO 3.81
- LEVI 79.50
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About LEVI Levi Strauss & Co
Levi Strauss & Co is involved in designing, marketing, and selling products that include jeans, casual and dresses pants, tops, shorts, skirts, jackets, footwear, and related accessories directly or through third parties and licensees for men, women, and children under Levi's, Dockers, Signature by Levi Strauss & Co. and Denizen brands. The company manages its business according to three regional segments: the Americas, which is the key revenue driver; Europe; and Asia.